论文部分内容阅读
目的观察和分析对胃溃疡患者应用雷贝拉唑和克拉霉素联合阿莫西林进行临床治疗的效果。方法胃溃疡患者106例随机分为对照组和观察组,每组53例。其中对照组采用奥美拉唑、克拉霉素联合阿莫西林进行治疗,观察组采用雷贝拉唑、克拉霉素联合阿莫西林进行治疗,并统计、对比和分析两组患者的临床诊治情况和效果。结果统计学分析显示,观察组的临床总有效率(96.23%)明显优于对照组(83.02%,),组间对比差异具有统计学意义(P<0.05)。结论对胃溃疡患者采用雷贝拉唑和克拉霉素联合阿莫西林进行治疗,具有良好的临床疗效,且安全性高,是一种安全、有效、理想、科学的临床治疗措施。
Objective To observe and analyze the clinical effect of rabeprazole and clarithromycin combined with amoxicillin in patients with gastric ulcer. Methods 106 cases of gastric ulcer patients were randomly divided into control group and observation group, 53 cases in each group. The control group was treated with omeprazole, clarithromycin and amoxicillin. The observation group was treated with rabeprazole, clarithromycin and amoxicillin, and the clinical diagnosis and treatment of the two groups were statistically analyzed and compared And effect. Results The statistical analysis showed that the total effective rate (96.23%) in the observation group was significantly better than that in the control group (83.02%). The difference between the two groups was statistically significant (P <0.05). Conclusion The treatment of patients with gastric ulcer with rabeprazole and clarithromycin combined with amoxicillin has good clinical efficacy, and high safety, is a safe, effective, ideal and scientific clinical treatment.